Wed 09 Feb 2022
New COVID-19 treatments coming to a community near you
William Franks will provide an overview on the two new oral treatments approved for use in Australia for COVID-19 – nirmatrelvir-ritonavir (Paxlovid) and molnupiravir (Lagevrio).
This will be followed by a panel discussion on the challenges and opportunities for pharmacists managing patients on COVID-19 disease modifying treatments with representation from various states.
SHPA are pleased to make this important COVID-19 treatment webinar free for all healthcare professionals.
This webinar will be delivered online via Zoom. You will need to register with Zoom using the following link: https://us06web.zoom.us/webinar/register/WN_GKl5zS7NTMqhoL9Le3Dlwg
After registering, you will receive a confirmation email containing information about joining the event. This will include your unique access link. If you do not receive a second confirmation email, please check your spam/junk folders. If the email is not there, please contact events@adpha.au for further assistance.
We recommend using the Zoom app to join this webinar.
Please do not hesitate to contact us on events@adpha.au if you have any further questions.
Competency Standards:
- Standard 3.1.2 Assess medication management practices and needs
- Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber’
National Competency Standards Framework for Pharmacists in Australia, 2016
Accreditation:
This activity has been accredited for 1 hour of Group-1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2022/07.
Presenter:
- William Franks - Pharmacist lead, Antimicrobial Stewardship Metro North Hospital and Health Service, Brisbane, Qld
Chair:
- Jason Roberts - Member of the SHPA Infectious Diseases and Critical Care Leadership Committees | Professor of Medicine & NHMRC Leadership Fellow Level 2, University of Queensland Centre for Clinical Research & Director NHMRC Centre for Research Excellence – RESPOND (formerly REDUCE) - The University of Queensland | Interim Director, Herston Infectious Diseases Institute (HeIDI); Metro North Health | Pharmacist Consultant, Royal Brisbane and Women’s Hospital, Brisbane, Qld.
Panellists:
- Sonia Koning - Member of the SHPA Infectious Diseases Committee | Lead Antimicrobial Stewardship Pharmacist - Eastern Health, Melbourne, Vic
- Caitlin Wallace - Senior Pharmacist, Infectious Diseases, Endocrinology, Immunology and Rheumatology - Royal Adelaide Hospital, Adelaide, SA
- Lucy Nair - Senior Improvement Lead, Medication Safety - Clinical Excellence Commission, Sydney, NSW
- Ian Coombes - Director of Pharmacy, Chair - Medication Safety Working Party & Chair - COVID Medicines and Pharmacy Planning response group - Royal Brisbane and Women’s Hospital | Academic Professor, School of Pharmacy - University of Queensland | Visiting Lecturer, Pharmacy Department - University of Peradeniya, Sri Lanka Pharmacy Department, Brisbane, Qld
- Jackson Crawn - Specialist Pharmacist - Infectious Diseases - Royal Hobart Hospital, Hobart, Tas
- Jeanie Misko - Medicines Information Senior Pharmacist, Pharmacy Department, South Metropolitan Health Service, Fiona Stanley Hospital, Murdoch, WA
Cancellation policy
- Membership rate is only applicable if you are a member at the time of the seminar. Should your membership lapse, or if you resign you will be invoiced for the difference in registration.
- Cancellations must be made in writing.
- Cancellations received before 6 weeks prior to the event will receive a full refund. Non-members will be charged a $50 handling fee.
- Cancellations received between 6 weeks and 1 week prior to the event will receive a 50% refund of the registration fee.
- Cancellations received less than a week prior to the event will NOT be refunded.
- SHPA reserve the right to cancel a seminar or make changes to the program
- If SHPA cancels or defers the event you will receive 100% of the registration fee but SHPA bears no responsibility for any costs incurred (such as flights, accommodation, travel or expenses) or loss of income.
- It is recommended that participants obtain adequate insurance cover for travel and accommodation.
- Transfer of registration – as an alternative to cancellation your registration may be transferred to another member of your organisation or another event (if the chosen seminar is a higher cost you will be subject to further charges). A request MUST be made in writing to the Federal Secretariat prior to the event.
- If you are unable to attend SHPA policy is that handouts can not be made available as ‘stand alone’ materials
Venue/Accessbility requirements
Catering/Dietary requirements
- Please complete the necessary section when registering online. SHPA will notify third parties such as caterers/suppliers of any dietary requirements.
- Whilst every care is taken to notify venues of dietary requirements, SHPA cannot guarantee completely allergy free meals, nor be held responsible for any adverse reaction. Any registrant who has notified SHPA of a dietary requirement should make themselves known to the seminar coordinator and/or venue staff upon their arrival.
- Some dietary requirements such as Kosher meals may incur an additional cost which is the responsilbility of the delegate. SHPA will notify you in advance.
Recording/Filming
- Recording and/or filming is not permitted by registrants. Please note this event may be recorded for the SHPA website and/or photos may be taken for use in SHPA resources and publications.
- Registrants are not permitted to record or film any part of SHPA events in any format including audio recording or video recording or through use of mobile devices for filming
Registration
- Numbers are capped so book early to avoid disappointment. Please note the only way to guarantee a space is to register online. Please ensure you register prior to booking your flights and accommodation.
- If you do not receive a confirmation email then you are not registered for the event and will not be able to be accommodated on the day of the event. If you are following up on registration please ensure you contact the Federal Secretariat at least a week prior to the event.
Disclaimer
The SHPA website contains guidelines, policies, procedures, information and various data which have been prepared by SHPA. Whilst the information contained on this site has been reviewed with due care, SHPA does not warrant or imply that the information is free from errors or omissions. Whilst the information is considered to be true and correct at the date of publication, changes in circumstances after publication may impact on the accuracy of the information.
The information presented on the website is made available on the understanding that SHPA, its employees and agents shall have no liability to the users for any loss, damage, cost or expenses arising from the use of the information through either action or inaction based on material on this site.
SHPA provides links from the SHPA website to sites that might be useful information sources to users of the website. Providing this information in no way assumes responsibility for the content contained on those websites.
Share this Post